StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)

Close on Nov 17, 2026Market cap $120.11MP/E –Yield –

Pyxis Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Pyxis Oncology's gross margin for the twelve months ending Dec 31, 2024 was 97.1%. For fiscal 2025 it was 82.8%, against 97.1% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202582.8%−14.3
FY2024Dec 31, 202497.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 202497.1%–

More Pyxis Oncology figures

See a number that looks wrong?